All
Upfront Chemotherapy Improves Survival in Bladder Cancer Subtype
December 12th 2017When given neoadjuvant chemotherapy before getting a radical cystectomy, patients with the basal subtype of muscle-invasive bladder cancer (MIBC) saw significantly improved overall survival (OS) compared to those who had a cystectomy alone, according to a recent study.
Elderly Patients Significantly Underrepresented in Hematology Clinical Trials
December 12th 2017Patients aged 75 years or older diagnosed with hematologic malignancies appear significantly underrepresented in clinical trials submitted to the U.S. Food and Drug Administration (FDA), according to a retrospective analysis.
Marking the Days and Remembering Cancer's Anniversaries
December 12th 2017From diagnosis to remission, my sister had cancer for nearly three years. Because of that, the cancer dates that mark my calendar are plentiful. I can recall most of them from memory without a second glance. While I was recently going through my old planners, I noticed just how many dates are filled with notations of cancer.
Keytruda Gets Priority Review for Lymphoma Subset
December 11th 2017Keytruda (pembrolizumab) was granted a priority review to a supplemental biologics license application (sBLA) to be used to treat adult and pediatric patients with relapsed or refractory primary mediastinal large B-cell lymphoma (PMBCL).
Poor Quality of Life Experienced By 1 in 5 Caregivers of Transplant Recipients
December 11th 2017Previous studies have found that caregivers of HCT recipients have more sleep and sexual issues, more depressive symptoms and more loneliness, as well as less social support and less spiritual well-being than HCT recipients.
Young Breast Cancer Survivors Empowered Through Advocacy and Education
December 11th 2017“It was frustrating always being the youngest one in the waiting room, combined with the fact that there is just not a lot of data on this population. So, we are forced to make decisions in the absence of hard data. It’s frustrating to know that we’re the neglected cohort of the disease,” Petrides said.
Nine Honored for Their Dedication to Helping Patients With MPNs
December 9th 2017At this year's Annual ASH Meeting & Exposition, eight people were recognized as MPN Heroes, and, new this year, a ninth individual was honored as the program’s first Canadian MPN Champion - all for their commitment to the individual and commitment to the broader MPN community.
Addressing the Psychosocial Side of Childhood Cancer
December 8th 2017The Mattie Miracle Cancer Foundation is dedicated to addressing the psychological needs of children and families with childhood cancer. It also aims to educate health care providers about potential psychosocial effects of a diagnosis.
What Comes Next for Cancer Survivors?
December 4th 2017At the National Comprehensive Cancer Network® (NCCN)’s Patient Advocacy Summit – a meeting designed to share best practices for survivorship planning care among advocacy organizations – Yelak Biru shared his story of survivorship, and how he has been able to integrate multiple myeloma into his life for more than two decades.
Treatment Options Expanding in HER2-Positive Breast Cancer
December 4th 2017Treatment options for patients with HER2-positive breast cancer continue to expand, especially after the Food and Drug Administration (FDA) approval of Nerlynx (neratinib) earlier in 2017 and the more recent priority review designation of Perjeta (pertuzumab).
From War to an Even Bigger Battle
December 3rd 2017During his career doing humanitarian work in the Middle East and central Asia, Len Rodgers has been no stranger to adversity. In 1967, he and his family were evacuated from Lebanon during the Six-Day War. “I’ve seen just about every Middle East war since,” Rodgers says. But in 2003, he faced his biggest battle yet.